Skip to main content
Top
Published in: Medical Oncology 4/2012

01-12-2012 | Original Paper

Primary pure signet-ring cell adenocarcinoma of the urinary bladder: a report of three cases with an immunohistochemical study

Author: Tadashi Terada

Published in: Medical Oncology | Issue 4/2012

Login to get access

Abstract

Although several case series of primary signet-ring cell adenocarcinoma (SRCA) of the urinary bladder (UB) have been published, primary pure SRCA of the UB composed exclusively of signet-ring cells is rare. In addition, there have been no comprehensive studies of immunohistochemical studies of primary SRCA of the UB. This report shows immunohistochemical profiles of 3 cases of primary SRCA of UB. The age of patients was 37, 43, and 84 years. The male-to-female ratio was 2:1. One specimen was cystectomy, and other two specimens were transurethral bladder tumorectomy. Two patients died of bladder tumor 12 and 16 months after the diagnosis, and one patient is now alive 6 months after the diagnosis. Histologically, all the three tumors were composed exclusively of SRCA cells. Histochemically, all tumors contained neutral and acidic mucins. Immunohistochemically, consistent findings were positive cytokeratin (CK) AE1/3, CK CAM5.2, CK8, CK18, CK19, CK20, p53, Ki-67 (30, 50, 70%), MUC1, and MUC2. CK34BE12, CK5/6, CK14, EMA, p63, vimentin, and MUC6 were consistently negative. CK7 was positive in 1/3, CA19-9 1/3, and MUC5AC 2/3 cases. These data may provide basic knowledge of SRCA of the UB. In conclusion, the author presents three cases of primary pure SRCA with an emphasis of immunohistochemical findings.
Literature
1.
go back to reference Choi H, Lamb S, Pintar K, Jacobs SC. Primary signet ring cell carcinoma of the urinary bladder. Cancer. 1984;53:1985–90.PubMedCrossRef Choi H, Lamb S, Pintar K, Jacobs SC. Primary signet ring cell carcinoma of the urinary bladder. Cancer. 1984;53:1985–90.PubMedCrossRef
2.
go back to reference DeFillipo N, Blute R, Klein LA. Signet-sing cell carcinoma of the bladder: evaluation of three cases with review of literature. Urology. 1987;29:479–83.PubMedCrossRef DeFillipo N, Blute R, Klein LA. Signet-sing cell carcinoma of the bladder: evaluation of three cases with review of literature. Urology. 1987;29:479–83.PubMedCrossRef
3.
go back to reference Blute ML, Engen DE, Travis WD, Kvols LK. Primary signet ring cell adenocarcinoma of the bladder. J Urol. 1989;141:17–21.PubMed Blute ML, Engen DE, Travis WD, Kvols LK. Primary signet ring cell adenocarcinoma of the bladder. J Urol. 1989;141:17–21.PubMed
4.
go back to reference Grignon DJ, Ro JY, Ayala AG, Johnson DE. Primary signet-ring cell carcinoma of the urinary bladder. Am J Clin Pathol. 1991;95:13–20.PubMed Grignon DJ, Ro JY, Ayala AG, Johnson DE. Primary signet-ring cell carcinoma of the urinary bladder. Am J Clin Pathol. 1991;95:13–20.PubMed
5.
go back to reference Torenbeek R, Koot RA, Blomjous CE, De Bruin PC, Newling DW, Meijer CJ. Primary signet-sing cell carcinoma of the urinary bladder. Histopathology. 1996;28:33–40.PubMedCrossRef Torenbeek R, Koot RA, Blomjous CE, De Bruin PC, Newling DW, Meijer CJ. Primary signet-sing cell carcinoma of the urinary bladder. Histopathology. 1996;28:33–40.PubMedCrossRef
6.
go back to reference Kunze E, Krassenkova I, Fayyazi A. Tumor-associated neoexpression of the pS2 peptide and MUC5AC mucin in primary adenocarcinoma and signet ring cell carcinoma of the urinary bladder. Histol Histopathol. 2008;23:539–48.PubMed Kunze E, Krassenkova I, Fayyazi A. Tumor-associated neoexpression of the pS2 peptide and MUC5AC mucin in primary adenocarcinoma and signet ring cell carcinoma of the urinary bladder. Histol Histopathol. 2008;23:539–48.PubMed
7.
go back to reference Del Sordo R, Bellezza G, Colella R, Mameli MG, Sidoni A, Cavaliere A. Primary signet-ring cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 5 cases. Appl Immunohistochem Mol Morphol. 2009;17:18–22.PubMedCrossRef Del Sordo R, Bellezza G, Colella R, Mameli MG, Sidoni A, Cavaliere A. Primary signet-ring cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 5 cases. Appl Immunohistochem Mol Morphol. 2009;17:18–22.PubMedCrossRef
8.
go back to reference Thomas AA, Stephenson AJ, Campbell SC, Jones JS, Hansel DE. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder. Hum Pathol. 2009;40:108–16.PubMedCrossRef Thomas AA, Stephenson AJ, Campbell SC, Jones JS, Hansel DE. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder. Hum Pathol. 2009;40:108–16.PubMedCrossRef
9.
go back to reference Wang J, Wang FW. Clinical characteristics and outcome of patients with primary signet-ring cell carcinoma of the urinary bladder. Urol Int 2011 [Epub ahead of print]. Wang J, Wang FW. Clinical characteristics and outcome of patients with primary signet-ring cell carcinoma of the urinary bladder. Urol Int 2011 [Epub ahead of print].
10.
go back to reference Ayara AG, Oliva E, Tamboil P. Adenocarcima of urinary bladder. In: Eble JN, Sauter vG, Epstein JL, Sesterhenn IA editors. World Health Organization Clasification of Tumours. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC Press; 2004. Pp. 128–30. Ayara AG, Oliva E, Tamboil P. Adenocarcima of urinary bladder. In: Eble JN, Sauter vG, Epstein JL, Sesterhenn IA editors. World Health Organization Clasification of Tumours. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC Press; 2004. Pp. 128–30.
11.
go back to reference Murphy WM, Grignon DJ, Perlman EJ. Adenocarcinoma of the urinary bladder. In: Murphy WM, Grignon DJ, Perlman EJ, editors. AFIP Atlas of tumor of tumor pathology. Series 4. Tumors of the kidney, bladder, and related urinary structures. Whashington, DC: American Registry of Pathology; 2004. pp. 304–8. Murphy WM, Grignon DJ, Perlman EJ. Adenocarcinoma of the urinary bladder. In: Murphy WM, Grignon DJ, Perlman EJ, editors. AFIP Atlas of tumor of tumor pathology. Series 4. Tumors of the kidney, bladder, and related urinary structures. Whashington, DC: American Registry of Pathology; 2004. pp. 304–8.
12.
go back to reference Terada T, Kawaguchi M, Furukawa K, Sekido Y, Osamura Y. Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol Int. 2002;52:740–6.PubMedCrossRef Terada T, Kawaguchi M, Furukawa K, Sekido Y, Osamura Y. Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol Int. 2002;52:740–6.PubMedCrossRef
13.
go back to reference Terada T, Kawaguchi M. Primary clear cell adenocarcinoma of the peritoneum. Tohoku J Exp Med. 2005;206:271–5.PubMedCrossRef Terada T, Kawaguchi M. Primary clear cell adenocarcinoma of the peritoneum. Tohoku J Exp Med. 2005;206:271–5.PubMedCrossRef
Metadata
Title
Primary pure signet-ring cell adenocarcinoma of the urinary bladder: a report of three cases with an immunohistochemical study
Author
Tadashi Terada
Publication date
01-12-2012
Publisher
Springer US
Published in
Medical Oncology / Issue 4/2012
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-011-0122-7

Other articles of this Issue 4/2012

Medical Oncology 4/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.